ES2068623T3 - Disminucion de los niveles de colesterol en sangre usando eteres de celulosa. - Google Patents

Disminucion de los niveles de colesterol en sangre usando eteres de celulosa.

Info

Publication number
ES2068623T3
ES2068623T3 ES92103867T ES92103867T ES2068623T3 ES 2068623 T3 ES2068623 T3 ES 2068623T3 ES 92103867 T ES92103867 T ES 92103867T ES 92103867 T ES92103867 T ES 92103867T ES 2068623 T3 ES2068623 T3 ES 2068623T3
Authority
ES
Spain
Prior art keywords
cellulose
eteres
decrease
cholesterol levels
blood cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92103867T
Other languages
English (en)
Inventor
Daniel D Gallaher
Craig A Hassel
Kyung-Jae Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Application granted granted Critical
Publication of ES2068623T3 publication Critical patent/ES2068623T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN METODO PARA REDUCIR EL NIVEL DE COLESTEROL EN LA SANGRE DE LOS MAMIFEROS ADMINISTRANDO A ESTOS UN ETER DE CELULOSA HIDROSOLUBLE. LOS ETERES DE CELULOSA TIENEN UNA VISCOSIDAD, MEDIDA EN UNA SOLUCION ACUOSA AL 2% A 20 (GRADOS) C, DE AL MENOS ALREDEDOR DE 35 CPS. ES PREFERENTE LA ADMINISTRACION ORAL Y, EN UNA REALIZACION EL ETER CELULOSA HIDROSOLUBLE DE GRAN VISCOSIDAD ES HIDROXIPROPIL METILCELULOSA, CONTENIDA EN UN PRODUCTO ALIMENTICIO.
ES92103867T 1991-03-08 1992-03-06 Disminucion de los niveles de colesterol en sangre usando eteres de celulosa. Expired - Lifetime ES2068623T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66639291A 1991-03-08 1991-03-08
US07/840,178 US5721221A (en) 1991-03-08 1992-02-24 Lowering blood cholesterol levels using water soluble cellulose ethers

Publications (1)

Publication Number Publication Date
ES2068623T3 true ES2068623T3 (es) 1995-04-16

Family

ID=27099455

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92103867T Expired - Lifetime ES2068623T3 (es) 1991-03-08 1992-03-06 Disminucion de los niveles de colesterol en sangre usando eteres de celulosa.

Country Status (21)

Country Link
US (2) US5721221A (es)
EP (1) EP0503496B1 (es)
JP (3) JP3651894B2 (es)
KR (1) KR100216495B1 (es)
AT (1) ATE117555T1 (es)
AU (1) AU657301B2 (es)
CA (1) CA2062412C (es)
DE (1) DE69201255T2 (es)
DK (1) DK0503496T3 (es)
ES (1) ES2068623T3 (es)
FI (1) FI933893A (es)
GR (1) GR3015652T3 (es)
HK (1) HK1010036A1 (es)
HU (1) HUT65208A (es)
IE (1) IE67435B1 (es)
IL (1) IL101148A (es)
MX (1) MX9201014A (es)
NO (1) NO306284B1 (es)
UA (1) UA27782C2 (es)
WO (1) WO1992015313A1 (es)
ZA (1) ZA921691B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US6458378B1 (en) 1999-03-16 2002-10-01 The Iams Company Pet food composition for controlling postprandial glycemic response
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
US7001618B1 (en) 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
WO2003030916A1 (en) 2001-10-12 2003-04-17 Regents Of The University Of Minnesota Medical and nutritional applications of highly refined cellulose
US6899892B2 (en) * 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
US6835558B2 (en) * 2002-02-04 2004-12-28 General Mills, Inc. Beta-glucan compositions and process therefore
US20040109922A1 (en) * 2002-08-21 2004-06-10 Thai Huy Lam Fruit sponge
US20070123490A1 (en) * 2005-11-30 2007-05-31 Yokoyama Wallace H Preventing or reducing oxidative stress or oxidative cell injury
TW200729300A (en) * 2005-11-30 2007-08-01 Nuflare Technology Inc Film-forming method and film-forming equipment
CA2666670A1 (en) 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
JP2010506956A (ja) * 2006-10-20 2010-03-04 ダウ グローバル テクノロジーズ インコーポレイティド メタボリックシンドロームを予防または処置する方法
JP4979735B2 (ja) * 2009-05-19 2012-07-18 信越化学工業株式会社 油ちょう用ドウ組成物及び油ちょうされたドウ組成物の製造方法
JP2011087490A (ja) * 2009-10-21 2011-05-06 Shin-Etsu Chemical Co Ltd 食肉添加剤、ピックル液及び食肉加工品
JP2012217413A (ja) * 2011-04-12 2012-11-12 Shin-Etsu Chemical Co Ltd 起泡性乳組成物
KR20140077975A (ko) * 2011-10-19 2014-06-24 다우 글로벌 테크놀로지스 엘엘씨 포만감을 유발하는 방법 및 조성물
US20140234521A1 (en) * 2011-11-04 2014-08-21 Samsung Fine Chemicals Co., Ltd Low fat mayonnaise composition and method of producing the same
WO2014014752A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose
ITFI20120268A1 (it) * 2012-12-03 2014-06-04 Diopeite Consulting Ltd Composizioni farmaceutiche per il trattamento dell'obesita'
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701782A (en) * 1951-05-11 1955-02-08 Upjohn Co Method of making and aqueous suspension of methyl cellulose
US2802741A (en) * 1953-09-21 1957-08-13 Dow Chemical Co Cake mixes containing water-soluble cellulose ethers
US2883327A (en) * 1954-05-03 1959-04-21 Upjohn Co Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
US2831852A (en) * 1954-05-27 1958-04-22 Dow Chemical Co Water-soluble thermoplastic cellulose ethers
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3342805A (en) * 1964-05-27 1967-09-19 Dow Chemical Co Process for the manufacture of cellulose ethers
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3388082A (en) * 1965-11-01 1968-06-11 Dow Chemical Co Novel hydroxypropyl methyl cellulose ethers, a process for preparing the same, and compositions utilizing such ethers
US3627872A (en) * 1968-04-08 1971-12-14 Upjohn Co Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides
US3721735A (en) * 1970-07-15 1973-03-20 C Thiffault Compositions for and method of lowering cholesterol levels
US3709876A (en) * 1972-04-10 1973-01-09 Dow Chemical Co Water soluble hydroxyethyl methyl cellulose ether thickener for latex paint
GB1506217A (en) * 1975-08-26 1978-04-05 Taiho Pharmaceutical Co Ltd Oral antilipemic composition
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4109018A (en) * 1976-05-27 1978-08-22 Thompson Jerome B Low calorie diet bread
US4265879A (en) * 1977-09-13 1981-05-05 Monsanto Company Method for controlling blood triglycerides
US4284649A (en) * 1977-11-22 1981-08-18 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4175124A (en) * 1977-12-30 1979-11-20 The Quaker Oats Company Method of treating hypercholesterolemia
EP0005977A3 (en) * 1978-05-30 1980-01-09 The Speywood Laboratory Ltd. Bread containing gum and its manufacture
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
DK221879A (da) * 1978-10-02 1980-04-03 Sepywood Lab Ltd Gummi dets fremstilling og anvendelse
US4251519A (en) * 1979-07-30 1981-02-17 Anheuser-Busch, Incorporated Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels
US4362711A (en) * 1980-07-11 1982-12-07 Evreka Inc. Blood cholesterol level reducing agent and method
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
JPS58135805A (ja) * 1982-02-08 1983-08-12 Teijin Ltd アレルギー性鼻炎治療又は予防剤
US4461782A (en) * 1982-02-16 1984-07-24 The Procter & Gamble Company Low calorie baked products
US4451490A (en) * 1982-03-08 1984-05-29 General Foods Corporation High quality, reduced-calorie cake containing cellulose and process thereof
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4410693A (en) * 1982-08-12 1983-10-18 The Dow Chemical Company Process for preparing cellulose derivatives
US4923981A (en) * 1982-09-03 1990-05-08 Sbp, Inc. Use of parenchymal cell cellulose to improve comestibles
US4520017A (en) * 1983-02-04 1985-05-28 Tunc Deger C Method of reducing nutrient absorption
NZ207125A (en) * 1983-02-17 1986-07-11 Merrell Pharma Inc Bulk laxative composition containing water-soluble cellulose ether
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US4477657A (en) * 1983-07-08 1984-10-16 The Dow Chemical Company Process for preparing hydroxyalkylcellulose ethers
JPS60142911A (ja) * 1983-12-29 1985-07-29 Nippon Soda Co Ltd 口腔内組成物
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
US4614545A (en) * 1985-08-15 1986-09-30 The Dow Chemical Company Hydroxypropyl methyl cellulose thickening agents for organic liquids
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4820813A (en) * 1986-05-01 1989-04-11 The Dow Chemical Company Grinding process for high viscosity cellulose ethers
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
JPS63112959A (ja) * 1986-06-30 1988-05-18 Terumo Corp 炊飯した低カロリー穀物の製造方法
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4950140A (en) * 1987-09-14 1990-08-21 The Procter & Gamble Company Cookies containing psyllium
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
US4959466A (en) * 1988-01-25 1990-09-25 Arco Chemical Technology, Inc. Partially esterified polysaccharide (PEP) fat substitutes
US4846889A (en) * 1988-02-02 1989-07-11 The Dow Chemical Company Polymeric blend useful in thin-bed mortar compositions comprising a water-soluble cellulose ether and a water-insoluble, but water-dispersible polymer
US4900573A (en) * 1988-06-17 1990-02-13 The Dow Chemical Company Method of inhibiting oil adsorption in coated fried foods using hydroxypropyl methyl cellulose
CA1331535C (en) * 1988-10-03 1994-08-23 Paul Dale Leis Jr. Psyllium-containing products
FI900632A0 (fi) * 1989-02-10 1990-02-08 Alko Ab Oy Cellulosaderivator.
FI895708A0 (fi) * 1989-02-10 1989-11-29 Alko Ab Oy Vattenloeslig soenderdelningsprodukt.
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US4996063A (en) * 1989-06-30 1991-02-26 The United States Of America, As Represented By The Secretary Of Agriculture Method for making a soluble dietary fiber composition from oats
US5219599A (en) * 1990-02-23 1993-06-15 Lipidyne Corporation Artificial adipose
US5213829A (en) * 1990-02-23 1993-05-25 Lipidyne Corporation Meat products containing artificial edible adipose and methods of making
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
ATE206927T1 (de) * 1991-03-01 2001-11-15 Univ Michigan Aufnehmbare zubereitungen enthaltend wasserlösliche, hochviskose cellulosether
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions

Also Published As

Publication number Publication date
AU657301B2 (en) 1995-03-09
HU9302531D0 (en) 1993-12-28
EP0503496B1 (en) 1995-01-25
DE69201255D1 (de) 1995-03-09
CA2062412C (en) 2002-10-15
WO1992015313A1 (en) 1992-09-17
EP0503496A1 (en) 1992-09-16
JP2003155243A (ja) 2003-05-27
ZA921691B (en) 1993-11-17
ATE117555T1 (de) 1995-02-15
MX9201014A (es) 1992-09-01
JPH06505488A (ja) 1994-06-23
US5585366A (en) 1996-12-17
DK0503496T3 (da) 1995-04-10
GR3015652T3 (en) 1995-07-31
FI933893A0 (fi) 1993-09-06
KR100216495B1 (ko) 1999-08-16
DE69201255T2 (de) 1995-07-20
NO933104D0 (no) 1993-08-31
JP2007217424A (ja) 2007-08-30
IL101148A0 (en) 1992-11-15
IE67435B1 (en) 1996-04-03
IE920730A1 (en) 1992-09-09
NO933104L (no) 1993-08-31
JP3651894B2 (ja) 2005-05-25
AU1149392A (en) 1992-09-10
US5721221A (en) 1998-02-24
CA2062412A1 (en) 1992-09-09
FI933893A (fi) 1993-09-06
HK1010036A1 (en) 1999-06-11
HUT65208A (en) 1994-05-02
UA27782C2 (uk) 2000-10-16
JP4116861B2 (ja) 2008-07-09
IL101148A (en) 2001-10-31
NO306284B1 (no) 1999-10-18

Similar Documents

Publication Publication Date Title
ES2068623T3 (es) Disminucion de los niveles de colesterol en sangre usando eteres de celulosa.
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
ES2052016T3 (es) Composicion emulsionada.
BE899635A (fr) Compositions pharmaceutiques.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES2095476T3 (es) Producto alimentario liquido.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2038632T3 (es) Una preparacion para curar heridas y su procedimiento de elaboracion.
IT1256652B (it) Procedimento per la preparazione di una composizione farmaceutica che abbassa selettivamente il livello di lipidi del sangue
IL83044A0 (en) Diphenylpropanamines,their preparation and pharmaceutical compositions containing them
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
ES510245A0 (es) "un metodo para obtener una preparacion de insulina".
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
IT8349288A0 (it) Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
JPS5441320A (en) Slow release preparation and its manufacturing
DE3586457D1 (de) Solubilisierungsverfahren im moment der anwendung eines aktiven lipophilen prinzipes in waessriger loesung zum zweck der intravenoesen verabreichung.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
KR880002521A (ko) 약제 제형
ATE139703T1 (de) Aureobasidin enthaltendes arzneimittel
IT1186775B (it) Derivati nuobosidici aventi proprieta' antierpetiche,composizioni farmaceutiche che li contengono e procedimento per la preparazione degli ingredienti attivi
SE8303012L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 503496

Country of ref document: ES